Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q3

3750.TEDINET S100STK6
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥1.4bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.7bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥495m2023-04-01 → 2023-12-31Cons.Operating income
Operating income−¥516m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income−¥595m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥602m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥533m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax−¥710m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥553m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥723m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥552m2023-04-01 → 2023-12-31Cons.Profit loss
Net income−¥723m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥13.7bnat 2023-12-31Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.1bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥11.6bnat 2023-12-31Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥716mat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-61.92023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.312023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-80.952022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.092022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio13.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥134m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-12-31¥102m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-12-31¥102m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-12-31−¥418m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-12-31¥1.3bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.3bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-12-31¥58m
—segment totalrevenue2023-04-01 → 2023-12-31¥1.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥1.4bn
—segment totalsegment profit2023-04-01 → 2023-12-31−¥360m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥116m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-12-31−¥224m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-12-31−¥176m
—segment totalrevenue2022-04-01 → 2022-12-31¥1.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-12-31−¥400m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Other noiPrior1YTDDuration4370000JPY
Other noiCurrentYTDDuration10805000JPY
Non operating incomePrior1YTDDuration31657000JPY
Non operating incomeCurrentYTDDuration19451000JPY
Interest expenses noePrior1YTDDuration92478000JPY
Interest expenses noeCurrentYTDDuration118621000JPY
Arrangement fee noePrior1YTDDuration25000000JPY
Arrangement fee noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration177000JPY
Other noeCurrentYTDDuration1650000JPY
Non operating expensesPrior1YTDDuration117656000JPY
Non operating expensesCurrentYTDDuration120272000JPY
Ordinary incomePrior1YTDDuration-601827000JPY
Ordinary incomeCurrentYTDDuration-595452000JPY
Gain on forgiveness of debts eiPrior1YTDDuration－JPY
Gain on forgiveness of debts eiCurrentYTDDuration48441000JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration48441000JPY
Loss on sale of investments in capital of subsidiaries and associates elPrior1YTDDuration107628000JPY
Loss on sale of investments in capital of subsidiaries and associates elCurrentYTDDuration－JPY
Impairment loss elPrior1YTDDuration6295000JPY
Impairment loss elCurrentYTDDuration－JPY
Settlement package elPrior1YTDDuration－JPY
Settlement package elCurrentYTDDuration1700000JPY
Other elPrior1YTDDuration2374000JPY
Other elCurrentYTDDuration274000JPY
Extraordinary lossPrior1YTDDuration116298000JPY
Extraordinary lossCurrentYTDDuration1974000JPY
Income before dividends distribution from silent partnership income taxesPrior1YTDDuration-718125000JPY
Income before dividends distribution from silent partnership income taxesCurrentYTDDuration-548986000JPY
Dividends distribution from silent partnershipPrior1YTDDuration-8093000JPY
Dividends distribution from silent partnershipCurrentYTDDuration-16282000JPY
Income before income taxesPrior1YTDDuration-710032000JPY
Income before income taxesCurrentYTDDuration-532703000JPY
Income taxes currentPrior1YTDDuration1451000JPY
Income taxes currentCurrentYTDDuration1475000JPY
Income taxes deferredPrior1YTDDuration11218000JPY
Income taxes deferredCurrentYTDDuration17928000JPY
Income taxesPrior1YTDDuration12670000JPY
Income taxesCurrentYTDDuration19403000JPY
Profit lossPrior1YTDDuration-722703000JPY
Profit lossCurrentYTDDuration-552107000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration97000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration528000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-722800000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-552635000JPY
Profit lossPrior1YTDDuration-722703000JPY
Profit lossCurrentYTDDuration-552107000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass